Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 08, 2018

SELL
$42.62 - $73.59 $562,584 - $971,388
-13,200 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$23.52 - $58.17 $310,464 - $767,844
13,200 New
13,200 $603,000
Q4 2017

Feb 12, 2018

SELL
$16.95 - $23.48 $177,975 - $246,540
-10,500 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$16.75 - $20.66 $175,875 - $216,930
10,500
10,500 $187,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $2.95B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.